Manchester Capital Management LLC Abbott Laboratories Transaction History

Manchester Capital Management LLC

$829 Million
Q3 2024

A detailed history of Manchester Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Manchester Capital Management LLC holds 21,773 shares of ABT stock, worth $2.5 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

21,773

Previous 21,760 0.06%

Holding current value

$2.5 Million

Previous $2.26 Million 9.77%

% of portfolio

0.3%

Previous 0.28%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$100.07 - $118.13 $1,300 - $1,535	13 Added 0.06%	21,773 $2.48 Million
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $302,693 - $337,882	-3,005 Reduced 12.13%	21,760 $2.26 Million
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $509,487 - $562,705	4,652 Added 23.13%	24,765 $2.81 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $28,500 - $34,886	-316 Reduced 1.55%	20,113 $2.21 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $11,463 - $13,754	-120 Reduced 0.58%	20,429 $1.98 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $591,477 - $659,030	-5,869 Reduced 22.22%	20,549 $2.24 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $2.56 Million - $3.01 Million	26,418 New	26,418 $2.68 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $1.38 Million - $1.66 Million	-13,489 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $5,358 - $6,534	-47 Reduced 0.35%	13,489 $1.6 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $5,892 - $7,214	51 Added 0.38%	13,536 $1.91 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $54,246 - $60,012	-465 Reduced 3.33%	13,485 $1.59 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $1,375 - $1,618	-13 Reduced 0.09%	13,950 $1.62 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $1,632 - $1,923	-15 Reduced 0.11%	13,963 $1.67 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $26,985 - $29,405	-257 Reduced 1.81%	13,978 $1.53 Million
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $304,977 - $370,373	-3,328 Reduced 18.95%	14,235 $1.55 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $43,457 - $47,120	-531 Reduced 2.93%	17,563 $1.47 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $24,236 - $29,301	-366 Reduced 1.98%	18,094 $1.45 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $585,256 - $645,947	10,166 Added 122.57%	18,460 $1.13 Million
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $29,879 - $33,782	531 Added 6.84%	8,294 $497,000
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $1,610 - $1,724	30 Added 0.39%	7,763 $443,000
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $371,647 - $414,798	7,733	7,733 $413,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Account

Manchester Capital Management LLC Abbott Laboratories Transaction History